NCT05960266View on ClinicalTrials.gov

Immunological Analysis of Lymph Node Tissue After Intralymphatic Immunotherapy: A Prospective Case Control Study

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

November 23, 2023

Primary Completion Date

April 14, 2024

Study Completion Date

June 1, 2024

Conditions
HypersensitivityHay FeverRhinitis, Allergic, SeasonalRhinoconjunctivitis
Interventions
BIOLOGICAL

Polvac Grass+Rye

Aqueous suspension of a co-precipitate of allergen extract and tyrosine

Trial Locations (1)

8091

University Hospital Zurich, Zurich

All Listed Sponsors
lead

University of Zurich

OTHER

NCT05960266 - Immunological Analysis of Lymph Node Tissue After Intralymphatic Immunotherapy: A Prospective Case Control Study | Biotech Hunter | Biotech Hunter